Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Coherus Biosciences (CHRS) Q4 2023 Earnings
CHRS
13
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.75
-0.57
-0.39
-0.21
Details
Expected EPS
-0.206907
Actual EPS
-0.71
Surprise EPS
-0.5
Surprise Percent
+243.15%
Description
Coherus Biosciences (CHRS) has reported earnings of -0.71 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login